Less Ads, More Data, More Tools Register for FREE

Pin to quick picksECM.L Regulatory News (ECM)

  • There is currently no data for ECM

Trading Update

3 Oct 2017 07:00

RNS Number : 4601S
Electrocomponents PLC
03 October 2017
 

 

Electrocomponents plc has today issued a trading update ahead of publishing half-year results on 14 November 2017

 

Regions

Q1

Q2

H1 2018

 

Northern Europe

 

10%

 

13%

11%

Southern Europe

11%

12%

11%

Central Europe

11%

15%

13%

Total Europe

11%

13%

12%

Asia & Emerging Markets

18%

17%

17%

North America

16%

15%

16%

Group

13%

14%

13%

 

 

 

Our good start in Q1 has continued into Q2, as strong execution and a positive market backdrop combined to drive faster revenue growth and market share gains across all five of our regions.

· Revenue growth(1) of 13% in H1 to September 2017, with all five regions continuing to see double-digit underlying revenue growth.

o Continued strong momentum in eCommerce with 14% H1 revenue growth.

o An acceleration in growth for RS Pro, our own-brand business, in Q2 leading to growth of 10% in H1 revenue.

o Trading comparatives will toughen in H2 with underlying revenue growth(1) trends in the year to March 2017 of 2.1% in H1 and 7.5% in H2.

· We continue to make good progress on our initiatives to stabilise gross margin and now expect to see a modest improvement in gross margin for H1 compared to the previous year. We remain on track to deliver stable gross margins for the full year.

· We have invested in inventory during H1 to improve stock availability and support faster revenue growth and, as such, we expect to see a higher than normal weighting of cash flow to the second half of our year to March 2018.

· Given stronger than expected progress to date and some benefit from translational foreign exchange(2) we now expect half year headline profit before tax to be around £78m (H1 2017: £55.1m).

· We are taking advantage of the strong momentum in the business to increase investment in areas such as innovation and digital in H2 to support future growth. Consequently, we now expect to see a more even distribution of profits between H1 and H2 in the current financial year.

 

 

LEI: 549300KVXDURRKVW7R37

 

 

Enquiries:

David Egan

Group Finance Director

0207 239 8400

Polly Elvin

Head of Investor Relations & Corporate PR

0207 239 8427

Martin Robinson/David Allchurch

 

Tulchan Communications

020 73534200

 

Notes:

1) Revenue growth rates, unless otherwise stated, are adjusted for trading days and currency movements ("underlying sales growth/decline").

2) Our profits remain sensitive to movements in exchange rates on translation of overseas profits. Every 1 cent movement in Euro will have c. £1.2m impact on profits. Every 1 cent movement in US $ will have c. £0.4m impact on profits. We expect to see around £5m benefit to profits from sterling weakness upon translation of overseas profits during the first half using our H1 average exchange rate of 1.29 for dollar and 1.14 for euro. If 30 September rates were to persist for the balance of the year, we would see a benefit of around £5m upon translation of overseas profits for the full year. 

3) During H1, we saw an adverse impact from fewer trading days which negatively impacted revenues by around £16m. In the full year we expect around a £24m adverse impact upon revenues from fewer trading days.

 

Electrocomponents plc - Conference Call Dial in Instructions

Date:

Tuesday 3rd October

UK Time:

08.00h call

Telephone number:

+44 (0) 1452 55 55 66

PIN:

90190149

Chairman:

Lindsley Ruth

Electrocomponents plc - Replay Dial in Instructions (available until Tuesday 10th October)

Telephone number:

+44 (0) 1452 55 00 00

PIN:

90190149

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTUUSSRBAARRAA
Date   Source Headline
28th Jun 202110:00 amRNSNotice of Trading Update
25th Jun 20212:30 pmRNSDirector/PDMR Shareholding
17th Jun 202111:00 amRNSDirector/PDMR Shareholding
15th Jun 202112:00 pmRNSAnnual Financial Report
10th Jun 202111:00 amRNSDirector/PDMR Shareholding
1st Jun 20219:00 amRNSTotal Voting Rights
25th May 20217:00 amRNSFinal Results
24th May 20213:00 pmRNSHolding(s) in Company
4th May 20213:00 pmRNSDirector Declaration
4th May 20219:00 amRNSTotal Voting Rights
13th Apr 20217:00 amRNSTrading Statement
1st Apr 20219:00 amRNSTotal Voting Rights
30th Mar 202110:00 amRNSNotice of Trading Update
18th Mar 20212:30 pmRNSDirector/PDMR Shareholding
10th Mar 202110:00 amRNSAdditional Listing
1st Mar 20214:00 pmRNSDirector Declaration
1st Mar 202110:00 amRNSTotal Voting Rights
1st Mar 20217:00 amRNSAcquisition of John Liscombe Limited
8th Feb 20217:00 amRNSTrading Statement
4th Feb 202110:00 amRNSHolding(s) in Company
2nd Feb 20212:30 pmRNSDirector/PDMR Shareholding
1st Feb 20219:01 amRNSBlock listing Interim Review
1st Feb 20219:00 amRNSTotal Voting Rights
27th Jan 202110:00 amRNSNotice of Trading Update
13th Jan 20217:00 amRNSCompletion of Synovos acquisition
4th Jan 202110:46 amRNSTotal Voting Rights
21st Dec 20202:30 pmRNSDirector/PDMR Shareholding
16th Dec 20209:30 amRNSHolding(s) in Company
15th Dec 20202:35 pmRNSHolding(s) in Company
11th Dec 202011:00 amRNSDirectorate Change
10th Dec 20204:17 pmRNSResults of the Placing
10th Dec 20207:20 amRNSRetail Offer via PrimaryBid.com
10th Dec 20207:18 amRNSProposed Placing of Ordinary Shares
10th Dec 20207:14 amRNSStrategically Attractive Acquisitions and Placing
4th Dec 202010:00 amRNSHolding(s) in Company
3rd Dec 20204:05 pmRNSHolding(s) in Company
1st Dec 202010:00 amRNSTotal Voting Rights
20th Nov 202010:30 amRNSDirector/PDMR Shareholding
20th Nov 202010:30 amRNSRefinancing of Group Debt facilities
17th Nov 20203:25 pmRNSHolding(s) in Company
17th Nov 20202:30 pmRNSAdditional Listing
12th Nov 202011:28 amRNSDirector/PDMR Shareholding
10th Nov 202010:00 amRNSDividend Declaration
10th Nov 20207:00 amRNSHalf-year Report
2nd Nov 202010:30 amRNSTotal Voting Rights
8th Oct 20207:00 amRNSTrading Statement
6th Oct 20207:00 amRNSDirectorate Change
1st Oct 202010:00 amRNSTotal Voting Rights
21st Sep 202010:30 amRNSNotice of Trading Update
18th Sep 20201:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.